Jakob Sons's guest appearances

Jakob Sons

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

The Green Peak

The Cannabis Review 

Ryan Douglas

Peter Grinspoon

Vera Twomey

Nick Pateras

Darwin Millard

Michael Patterson

Mitchell Osak

Mark Reinders

Alexej Pikovsky

Narbé Alexandrian

Deepak Anand

Alfredo Pascual

Steve DeAngelo

Andrew DeAngelo

Rob Sechrist

OwlTail

Cansativa is creating an accessible ecosystem – together with you. As Cansativa Group, they are resolutely blazing new trails alongside governmental bodies, administrators, and our commercial partners as we are developing a dependable and diversified product and service landscape in Germany and Europe. Cannabis is an innovative future industry with enormous potential. They are the platform that makes cannabis available in Germany and Europe! Benedikt is a pioneer in building new business models and in taking them to scale. Benedikt has several years of experience in both strategy consulting and industry.

Cansativa is creating an accessible ecosystem – together with you. As Cansativa Group, they are resolutely blazing new trails alongside governmental bodies, administrators, and our commercial partners as we are developing a dependable and diversified product and service landscape in Germany and Europe. Cannabis is an innovative future industry with enormous potential. They are the platform that makes cannabis available in Germany and Europe! Benedikt is a pioneer in building new business models and in taking them to scale. Benedikt has several years of experience in both strategy consulting and industry.

Cansativa Group with Benedikt and Jakob Sons

On this episode, we are joined by Jakob Sons. Jakob is Co-Founder, Managing Director and General Counsel of Cansativa GmbH. From its headquarter in Moerfelden-Walldorf, Germany, Cansativa and its subsidiaries work to professionalize the medical cannabis market, eliminate stigmatization and to permanently reduce prices for patients. In 2019, Cansativa GmbH became the first European company to import medical cannabis from Australia. Topics: 1. The Cansativa Story 2. The European Opportunity 3. European Imports Vs European Homegrown  Twitter - @TheCannabisRev2       Episode Library - https://www.irishmedianetwork.com/the... Cansativa - https://www.cansativa.de/de/ 

On this episode, we are joined by Jakob Sons. Jakob is Co-Founder, Managing Director and General Counsel of Cansativa GmbH. From its headquarter in Moerfelden-Walldorf, Germany, Cansativa and its subsidiaries work to professionalize the medical cannabis market, eliminate stigmatization and to permanently reduce prices for patients. In 2019, Cansativa GmbH became the first European company to import medical cannabis from Australia. Topics: 1. The Cansativa Story 2. The European Opportunity 3. European Imports Vs European Homegrown Twitter - @TheCannabisRev2       Episode Library - <a href="https://www.irishmedianetwork.com/the" rel="nofollow" target="_blank">https://www.irishmedianetwork.com/the</a>... Cansativa - <a href="https://www.cansativa.de/de/" rel="nofollow" target="_blank">https://www.cansativa.de/de/</a>

German Cannabis Will Be The Benchmark for Europe | Jakob Sons (Co-Founder @ Cansativa GmbH)

How should we try and regulate medical cannabis in Europe?This week we’re joined by Benedikt and Jakob Sons, Co-founders of Cansativa - German GMP and GDP certified cannabis and pharmaceutical wholesalers.  Together, we take a detailed look into the current medical cannabis regulations in Germany, including the differences between federal and state governance, cannabis’ status as both a medical product and narcotic, and we share some thoughts on how this sector should be regulated going forward.→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode77About CansativaCansativa provides independent market access and extensive warehousing and distribution capacities. Founded in 2017 and headquartered in Moerfelden-Walldorf, Germany, Cansativa is a GMP and GDP certified pharmaceutical company licensed for manufacturing, import and trade in pharmaceuticals as well as trade in controlled substances. Cansativa is committed to the goal of professionalizing the medical cannabis market, eliminating stigmatization surrounding it, and reducing prices for patients. Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of the “first movers” in the industry, it has become one of the largest importers and distributors of medical cannabis in Germany. The company supplies pharmacies and pharmaceutical wholesalers throughout Germany. With the newly obtained manufacturing authorization for both its sites, Cansativa strengthens the supply security of medical cannabis on the German market.ResourcesJoin Benedikt on LinkedIn: https://www.linkedin.com/in/johann-benedikt-sons-762a28103/Join Jakob on LinkedIn: https://www.linkedin.com/in/jakob-sons-795087133/Cansativa Website: https://www.cansativa.de/Medical cannabis distribution in Germany article from MJBiz: https://mjbizdaily.com/video-inside-look-at-medical-cannabis-distribution-in-germany/

<h1>How should we try and regulate medical cannabis in Europe?</h1> This week we’re joined by Benedikt and Jakob Sons, Co-founders of Cansativa - German GMP and GDP certified cannabis and pharmaceutical wholesalers.  Together, we take a detailed look into the current medical cannabis regulations in Germany, including the differences between federal and state governance, cannabis’ status as both a medical product and narcotic, and we share some thoughts on how this sector should be regulated going forward. → View full show notes and summary here: <a href="https://www.cannabis-conversation.com/blogs/episode77" rel="nofollow" target="_blank">https://www.cannabis-conversation.com/blogs/episode77</a> <h1>About Cansativa</h1>Cansativa provides independent market access and extensive warehousing and distribution capacities. Founded in 2017 and headquartered in Moerfelden-Walldorf, Germany, Cansativa is a GMP and GDP certified pharmaceutical company licensed for manufacturing, import and trade in pharmaceuticals as well as trade in controlled substances. Cansativa is committed to the goal of professionalizing the medical cannabis market, eliminating stigmatization surrounding it, and reducing prices for patients. Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of the “first movers” in the industry, it has become one of the largest importers and distributors of medical cannabis in Germany. The company supplies pharmacies and pharmaceutical wholesalers throughout Germany. With the newly obtained manufacturing authorization for both its sites, Cansativa strengthens the supply security of medical cannabis on the German market. <h1>Resources</h1>Join Benedikt on LinkedIn: <a href="https://www.linkedin.com/in/johann-benedikt-sons-762a28103/" rel="nofollow" target="_blank">https://www.linkedin.com/in/johann-benedikt-sons-762a28103/</a>Join Jakob on LinkedIn: <a href="https://www.linkedin.com/in/jakob-sons-795087133/" rel="nofollow" target="_blank">https://www.linkedin.com/in/jakob-sons-795087133/</a>Cansativa Website: <a href="https://www.cansativa.de/" rel="nofollow" target="_blank">https://www.cansativa.de/</a>Medical cannabis distribution in Germany article from MJBiz: <a href="https://mjbizdaily.com/video-inside-look-at-medical-cannabis-distribution-in-germany/" rel="nofollow" target="_blank">https://mjbizdaily.com/video-inside-look-at-medical-cannabis-distribution-in-germany/</a>

EPISODE #77 Medical Cannabis Regulation with Benedikt and Jakob Sons, Co-founders at Cansativa